| Entry |
|
|---|
| Name |
Dazmegrel (USAN/INN) |
|---|
| Formula |
C16H17N3O2
|
|---|
| Exact mass |
283.1321
|
|---|
| Mol weight |
283.32
|
|---|
| Structure |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
|
|---|
| Efficacy |
Platelet aggregation inhibitor, Thromboxane A2 (TXA2) synthase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
D03661 Dazmegrel
Target-based classification of drugs [BR:br08310]
Enzymes
Isomerases (EC5)
Thromboxane-A synthase
TBXAS1 (CYP5A1)
D03661 Dazmegrel (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 21
1 C8x C 24.3196 -16.2013
2 C8x C 24.3196 -14.7991
3 C8x C 25.5114 -14.0980
4 C8y C 26.7733 -14.7991
5 C8y C 26.7733 -16.2013
6 C8x C 25.5114 -16.9024
7 N4y N 28.0353 -14.3785
8 C8y C 28.8766 -15.5002
9 C8y C 28.0353 -16.6219
10 C1a C 30.2787 -15.5002
11 C1b C 28.0353 -18.0219
12 N4y N 29.2590 -18.7291
13 C8x C 29.2590 -20.1291
14 C8x C 30.5905 -20.5618
15 N5x N 31.4134 -19.4291
16 C8x C 30.5905 -18.2965
17 C1b C 28.0353 -12.9785
18 C1b C 29.2862 -12.2565
19 C6a C 30.4760 -12.9439
20 O6a O 31.6664 -12.2568
21 O6a O 30.4758 -14.3498
BOND 23
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 2
10 5 9 1
11 8 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 12 16 1
19 7 17 1
20 17 18 1
21 18 19 1
22 19 20 1
23 19 21 2
|
|---|
